Russell Barbour, PhD
Associate Research Scientist in Biostatistics and Lecturer (Macmillan Center)DownloadHi-Res Photo
Cards
Additional Titles
Associate Director for Research Methods and Analysis, Center for Interdisciplinary Research on AIDS
Contact Info
About
Titles
Associate Research Scientist in Biostatistics and Lecturer (Macmillan Center)
Associate Director for Research Methods and Analysis, Center for Interdisciplinary Research on AIDS
Biography
My academic training is in human ecology, so I take an ecological perspective to my work in epidemiological statistics. Of special interest is data that is correlated by space, social networks or other factors. Missing data and other lacunae in data sets has become my specialty
Appointments
Biostatistics
Associate Research ScientistPrimary
Other Departments & Organizations
- Biostatistics
- Biostatistics
- Center for Interdisciplinary Research on AIDS
- Yale School of Public Health
- Yale School of Public Health - NEW
- Yale-UPR Integrated HIV Basic and Clinical Sciences Initiative
Education & Training
- PhD
- Yale University, Yale School of Forestry and Environmental Studies/Human Ecology (2002)
- BA
- George Washington University (1970)
Research
Overview
Medical Research Interests
Biostatistics; Diseases; Statistics as Topic
Public Health Interests
Infectious Diseases
Research at a Glance
Yale Co-Authors
Frequent collaborators of Russell Barbour's published research.
Publications Timeline
A big-picture view of Russell Barbour's research output by year.
Robert Heimer, PhD
Lauretta Grau, PhD
Kaveh Khoshnood, PhD, MPH
Baylah Tessier-Sherman
Forrest W. Crawford, PhD
Frederick Lewis Altice, MD, MA
18Publications
421Citations
Publications
2023
Technical violations and infractions are drivers of disengagement from methadone treatment among people with opioid use disorder discharged from Connecticut jails 2014–2018
Marotta P, Hass A, Viera A, Doernberg M, Barbour R, Grau L, Heimer R. Technical violations and infractions are drivers of disengagement from methadone treatment among people with opioid use disorder discharged from Connecticut jails 2014–2018. Substance Abuse Treatment, Prevention, And Policy 2023, 18: 43. PMID: 37420271, PMCID: PMC10329353, DOI: 10.1186/s13011-023-00541-2.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsMale and female Asians living with HIV: a text-mining analysis comparing their concerns
Chen W, Barbour R. Male and female Asians living with HIV: a text-mining analysis comparing their concerns. Frontiers In Psychology 2023, 14: 1114731. PMID: 37251024, PMCID: PMC10213259, DOI: 10.3389/fpsyg.2023.1114731.Peer-Reviewed Original ResearchConceptsGender-based dataGender minoritiesDepth interviewsGender rolesFamily relationshipsTerms of menHIV/AIDSHIV-positive individualsHIV-positive menText mining analysisHIV preventionSexual preferenceSelf-management strategiesKey concernUnited StatesParticipants' responsesHIV serostatusHIV disclosureTreatment needsHealthcare providersFamily membersPLWHAPeopleFuture interventionsSan Francisco
2021
Reported history and correlates of drug overdose among people who inject drugs in Lebanon
Khoshnood K, Sheb F, Khouri D, Aaraj E, Barbour R, Crawford F, Mokhbat J, Parpia A, Heimer R. Reported history and correlates of drug overdose among people who inject drugs in Lebanon. Eastern Mediterranean Health Journal 2021, 27: 571-579. DOI: 10.26719/2021.27.6.571.Peer-Reviewed Original ResearchCitationsAltmetricConceptsSubstance use treatmentCorrelates of drugDrug overdoseOpioid overdoseDrug treatmentNon-fatal opioid overdoseUse treatmentOverdose prevention programsInfectious disease test resultsBetter epidemiologic dataDisease test resultsDrug use historySexual risk behaviorsHistory of incarcerationEffective treatment programsRespondent-driven samplingEligible PWIDDrug injectionEpidemiologic dataFirst drugAverage ageLebanese menHistory of arrestPrevention programsRisk behaviors
2014
Hepatitis C virus seroprevalence among people who inject drugs and factors associated with infection in eight Russian cities
Heimer R, Eritsyan K, Barbour R, Levina OS. Hepatitis C virus seroprevalence among people who inject drugs and factors associated with infection in eight Russian cities. BMC Infectious Diseases 2014, 14: s12. PMID: 25253447, PMCID: PMC4178532, DOI: 10.1186/1471-2334-14-s6-s12.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsHepatitis C virusRespondent-driven samplingHIV-1Hepatitis C virus (HCV) seroprevalencePositive HCV serostatusInjection drug useLarger social network sizeHarm reduction programsHCV-positive serostatusBetter prevention programsHCV prevalenceHCV serostatusHCV epidemicMean ageC virusInjection paraphernaliaVirus seroprevalenceSerological testingRisk populationsBlood specimensCity-level factorsPWIDDrug usePrevention programsLonger durationStatistical Power of Alternative Structural Models for Comparative Effectiveness Research: Advantages of Modeling Unreliability.
Coman E, Iordache E, Dierker L, Fifield J, Schensul J, Suggs S, Barbour R. Statistical Power of Alternative Structural Models for Comparative Effectiveness Research: Advantages of Modeling Unreliability. Journal Of Modern Applied Statistical Methods 2014, 13: 71-90. PMID: 26640421, PMCID: PMC4667813, DOI: 10.22237/jmasm/1398917100.Peer-Reviewed Original ResearchCitationsAltering dynamic pathways to reduce substance use among youth: Changes achieved by dynamic coupling
Coman E, Lin C, Suggs S, Iordache E, McArdle J, Barbour R. Altering dynamic pathways to reduce substance use among youth: Changes achieved by dynamic coupling. Addiction Research & Theory 2014, 22: 505-514. DOI: 10.3109/16066359.2014.892932.Peer-Reviewed Original ResearchCitationsAltmetric
2013
Drug users in Hanoi, Vietnam: factors associated with membership in community-based drug user groups
Hayes-Larson E, Grau LE, Khoshnood K, Barbour R, Khuat OT, Heimer R. Drug users in Hanoi, Vietnam: factors associated with membership in community-based drug user groups. Harm Reduction Journal 2013, 10: 33. PMID: 24268108, PMCID: PMC4176489, DOI: 10.1186/1477-7517-10-33.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsDrug user groupsResult of membershipDomains of knowledgeInjection-related harmsLongitudinal studyGreater historyDrug usePost-hoc evaluationMembershipLow statistical powerFurther longitudinal studiesQuality of lifeUser groupsFaceHigh levelsPeersMore attentionHealth issuesMultivariate modelBeingHarm reductionDrug usersKnowledge variablesHarmVariablesEffect of systematic ergonomic hazard identification and control implementation on musculoskeletal disorder and injury risk.
Cantley LF, Taiwo OA, Galusha D, Barbour R, Slade MD, Tessier-Sherman B, Cullen MR. Effect of systematic ergonomic hazard identification and control implementation on musculoskeletal disorder and injury risk. Scandinavian Journal Of Work, Environment & Health 2013, 40: 57-65. PMID: 24142048, PMCID: PMC4096997, DOI: 10.5271/sjweh.3394.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsMusculoskeletal disordersRelative riskInjury riskErgonomic hazardsHC groupRisk reductionInjury risk reductionInjury historyWorker injury riskInjury outcomesStudy periodRiskControl initiativesDisordersParticipatory ergonomicsGroupHazard identificationTemporal trendsErgonomic standardsInjuryPersonsSeroprevalence of HIV, hepatitis B virus, and HCV among injection drug users in Connecticut: understanding infection and coinfection risks in a nonurban population.
Akselrod H, Grau LE, Barbour R, Heimer R. Seroprevalence of HIV, hepatitis B virus, and HCV among injection drug users in Connecticut: understanding infection and coinfection risks in a nonurban population. American Journal Of Public Health 2013, 104: 1713-21. PMID: 24134382, PMCID: PMC3990658, DOI: 10.2105/ajph.2013.301357.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsInjection drug usersHepatitis B virusDrug use durationSubstance abuse treatmentB virusRisk factorsCriminal justice involvementDrug usersAbuse treatmentAdult injection drug usersSeroprevalence of HIVInjection drug usePotential risk factorsSignificant predictorsUse durationMultiple viral infectionsEffective harm reduction strategiesHarm reduction strategiesJustice involvementHCV seroprevalenceInjection useInterim analysisViral infectionDrug useSerological testsAssociations Between Injection Risk and Community Disadvantage Among Suburban Injection Drug Users in Southwestern Connecticut, USA
Heimer R, Barbour R, Palacios WR, Nichols LG, Grau LE. Associations Between Injection Risk and Community Disadvantage Among Suburban Injection Drug Users in Southwestern Connecticut, USA. AIDS And Behavior 2013, 18: 452-463. PMID: 23921583, PMCID: PMC3917972, DOI: 10.1007/s10461-013-0572-3.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsMeSH KeywordsAdultConnecticutDrug UsersFemaleHarm ReductionHealth Services AccessibilityHumansInterviews as TopicLongitudinal StudiesMaleNeedle SharingPrevalenceResidence CharacteristicsRisk FactorsSocial EnvironmentSocioeconomic FactorsSubstance Abuse, IntravenousSubstance-Related DisordersSuburban Health ServicesSuburban PopulationYoung AdultConceptsHarm reduction servicesInjection riskReduction servicesAbuse treatmentInjection drug useInjection drug usersRisky injection practicesPoor social supportDisadvantaged census tractsSubstance abuse treatmentDrug abuse treatmentPatterns of heroinRespondent-driven samplingHepatitis BInfluence of residenceSevere depressionOpioid overdosesSerological testingOverdose deathsGeneral populationInjection practicesDrug usersDrug useYounger ageRisk behaviors
News
News
Get In Touch
Contacts
Locations
CIRA
Academic Office
135 College Street, Ste Room 206
New Haven, CT 06510